Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’
View through CrossRef
Although less than 1% of patients with the antiphospholipid syndrome (APS) develop the catastrophic variant, its potentially lethal outcome emphasizes its importance in clinical medicine today. However, the rarity of this variant makes it extraordinarily difficult to study in any systematic way. In order to put together all of the published case reports as well as the new diagnosed cases from all over the world, an international registry of patients with catastrophic APS (CAPS Registry) was created in 2000 by the European Forum on Antiphospholipid Antibodies (see http://www.med.ub.es/MIMMUN/FORUM/CAPS.HTM). Currently, it documents the entire clinical, laboratory and therapeutic data of more than 300 patients whose data has been fully registered.
Title: Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’
Description:
Although less than 1% of patients with the antiphospholipid syndrome (APS) develop the catastrophic variant, its potentially lethal outcome emphasizes its importance in clinical medicine today.
However, the rarity of this variant makes it extraordinarily difficult to study in any systematic way.
In order to put together all of the published case reports as well as the new diagnosed cases from all over the world, an international registry of patients with catastrophic APS (CAPS Registry) was created in 2000 by the European Forum on Antiphospholipid Antibodies (see http://www.
med.
ub.
es/MIMMUN/FORUM/CAPS.
HTM).
Currently, it documents the entire clinical, laboratory and therapeutic data of more than 300 patients whose data has been fully registered.
Related Results
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract
Introduction
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
Catastrophic Antiphospholipid Syndrome: A Review
Catastrophic Antiphospholipid Syndrome: A Review
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by thrombotic or obstetric events occurring in individuals who have persistent antiphospholipid antib...
Surfactant system of the lungs in antiphospholipid syndrome under the conditions of administration of the immunosuppressive agent FTY-720
Surfactant system of the lungs in antiphospholipid syndrome under the conditions of administration of the immunosuppressive agent FTY-720
Antiphospholipid syndrome (APS) is a thrombophilic disease in the pathogenesis of which the leading role belongs to antibodies reacting with antigenic determinants of phospholipids...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Retinal manifestations in catastrophic antiphospholipid syndrome
Retinal manifestations in catastrophic antiphospholipid syndrome
AbstractPurpose We present a case report with an ocular vascular event and multiple organ thrombosis and dysfunction in the presence of antiphospholipid antibodies.Methods We repor...
Abstract OT-11-01: The informed genetics annotated patient registry: The iGAP registry
Abstract OT-11-01: The informed genetics annotated patient registry: The iGAP registry
Abstract
Background
Interest and knowledge about the genetics and biology of inherited risk of and progression of disease is growing. Physicians are i...
The state of cancer care in Russia. Analytical indicators: one-year mortality (population study at the federal district level)
The state of cancer care in Russia. Analytical indicators: one-year mortality (population study at the federal district level)
In February 2019, Russia's first Population-based Cancer Registry (PCR) was created at the federal district level with a database of more than 1 million 350 thousand obser...
COVID-19 and Catastrophic Antiphospholipid Syndrome
COVID-19 and Catastrophic Antiphospholipid Syndrome
One year after the beginning of the epidemic, mortality continues to be high despite several different protocols being tried. Critical patients with Covid 19 in some degree of orga...